From Name:
From Email:
To Name:
To Email:

Optional Message:

University of Chicago Partners with Industry to Develop Next-Generation Cancer Therapies

from The University of Chicago

A new collaboration between Celgene Corp. and the Recombinant Antibody Network — a consortium comprising research groups from the University of California-San Francisco, the University of Chicago and the University of Toronto — will support the development of next-generation, antibody-based cancer therapies. In this first industry partnership for the network, Celgene agreed to pay $25 million for the option to enter into future license agreements to develop and commercialize promising therapeutic antibodies to cancer-related targets. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063